Jonathan Rubin
Chief Tech/Sci/R&D Officer bij SUPERNUS PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Jonathan Rubin's current job is Senior VP-R&D, Chief Medical Officer at Supernus Pharmaceuticals, Inc. He previously worked as a Medical Director at Shire Development LLC, Chief Medical Officer at Alcobra Ltd., and Chief Medical Officer at Atentiv, Inc. Dr. Rubin received his undergraduate degree from Yale University, his MBA from Columbia Business School, and his doctorate from The University of Connecticut School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ASHTROM GROUP LTD.
0.14% | 29-06-2023 | 144 849 ( 0.14% ) | 2 M $ | 31-03-2024 |
| 23-02-2024 | 4 641 ( 0.01% ) | 158 305 $ | 31-03-2024 |
Actieve functies van Jonathan Rubin
| Bedrijven | Functie | Begin |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2021 |
Eerdere bekende functies van Jonathan Rubin
| Bedrijven | Functie | Einde |
|---|---|---|
| Atentiv, Inc. | Chief Tech/Sci/R&D Officer | 01-02-2020 |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Chief Tech/Sci/R&D Officer | 01-09-2017 |
| Shire Development LLC | Chief Tech/Sci/R&D Officer | - |
Opleiding van Jonathan Rubin
| Yale University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
| The University of Connecticut School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
| Atentiv, Inc. | |
| Shire Development LLC |
